Trial Profile
A Phase II Study of Radiotherapy and ZADAXIN's (Thymalfasin) Induced Abscopal Effect in Patients With Heavily Pretreated, Metastatic Colorectal Cancer
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2019
Price :
$35
*
At a glance
- Drugs Thymalfasin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 18 Jun 2019 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 02 Sep 2015 New trial record